As of 2:01pm ET
| -0.02 / -0.72%|
The 4 analysts offering 12-month price forecasts for CytRx Corp have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +228.47% increase from the last price of 2.74.
The current consensus among 4 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.